Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar Tovar

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Developmental and Comparative Immunology|July 11, 2017
The toll-like receptor ligands Hiltonol<sup>®</sup> (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii)Amanda L Patchett, Cesar Tovar, Lynn M Corcoran, et al.
Plos One|December 10, 2016
The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell LinesAmanda L Patchett, Jocelyn M Darby, Cesar Tovar, et al.
Immunology and Cell Biology|March 5, 2021
Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trialsAmanda L Patchett, Cesar Tovar, Nicholas B Blackburn, et al.
Plos One|April 28, 2018
Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour diseaseCesar Tovar, Amanda L Patchett, Vitna Kim, et al.
Developmental and Comparative Immunology|July 18, 2015
Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devilAmanda L Patchett, Roger Latham, Kate H Brettingham-Moore, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2015
Immunology of a Transmissible Cancer Spreading among Tasmanian DevilsGregory M Woods, Lauren J Howson, Gabriella K Brown, et al.
Anatomical Record (Hoboken, N.J. : 2007)|March 26, 2014
Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumorsLauren J Howson, Katrina M Morris, Takumi Kobayashi, et al.
Oncotarget|April 18, 2018
Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cellsAmanda L Patchett, Richard Wilson, Jac C Charlesworth, et al.
Immunology and Cell Biology|April 20, 2016
Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cellsGabriella K Brown, Cesar Tovar, Anne A Cooray, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2013
Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancerHannah V Siddle, Alexandre Kreiss, Cesar Tovar, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Developmental and Comparative Immunology|July 11, 2017
The toll-like receptor ligands Hiltonol<sup>®</sup> (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii)Amanda L Patchett, Cesar Tovar, Lynn M Corcoran, et al.
Plos One|December 10, 2016
The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell LinesAmanda L Patchett, Jocelyn M Darby, Cesar Tovar, et al.
Immunology and Cell Biology|March 5, 2021
Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trialsAmanda L Patchett, Cesar Tovar, Nicholas B Blackburn, et al.
Plos One|April 28, 2018
Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour diseaseCesar Tovar, Amanda L Patchett, Vitna Kim, et al.
Developmental and Comparative Immunology|July 18, 2015
Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devilAmanda L Patchett, Roger Latham, Kate H Brettingham-Moore, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2015
Immunology of a Transmissible Cancer Spreading among Tasmanian DevilsGregory M Woods, Lauren J Howson, Gabriella K Brown, et al.
Anatomical Record (Hoboken, N.J. : 2007)|March 26, 2014
Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumorsLauren J Howson, Katrina M Morris, Takumi Kobayashi, et al.
Oncotarget|April 18, 2018
Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cellsAmanda L Patchett, Richard Wilson, Jac C Charlesworth, et al.
Immunology and Cell Biology|April 20, 2016
Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cellsGabriella K Brown, Cesar Tovar, Anne A Cooray, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2013
Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancerHannah V Siddle, Alexandre Kreiss, Cesar Tovar, et al.
Pageof 2